Handelsavisen
prelaunch
Companies Healthcare LENS.NS
LE
LENS.NS NSE (India) Medical Equipment, Supplies & Distribution

Lenskart Solutions Ltd

$510,75
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
2,8 %
ROE
4,9 %
Net margin
4,5 %
Debt / equity
0,42
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Lenskart Solutions Ltd operates in the healthcare services and equipment industry, primarily offering eyewear and related products through a combination of online and physical retail channels.

Business. Lenskart Solutions Ltd (LENS.NS) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through product sales, focusing on the provision of healthcare-related goods and services. Headquartered in India, the company is listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY15 analysts
11 buy3 hold1 sell
Avg 12m price target541,73

Analyst recommendations

15 analysts · consensus Buy
Buy11
Hold3
Sell1
12-month price target
541,73
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
15 analysts · indicative
Ownership
not yet wired
Profitability
4,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning LENS.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to LENS.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Lenskart Solutions Ltd (LENS.NS) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through product sales, focusing on the provision of healthcare-related goods and services. Headquartered in India, the company is listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Lenskart Solutions Ltd maintains a debt-to-equity ratio of 0.42, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 1.94, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its liquidity flexibility.

    In terms of profitability, Lenskart's return on equity (ROE) is 4.88%, and its return on assets (ROA) is 2.84%. These figures are below the typical thresholds for strong performance in the retail and healthcare equipment sectors, indicating that the company is generating modest returns relative to its equity and asset base.

    The company's revenue is primarily concentrated in India, with a significant portion derived from its online and physical retail operations. While the input data does not provide a detailed breakdown of geographic exposure, the company's operations are largely domestic, which may expose it to regional economic and regulatory risks.

    Lenskart's growth trajectory is reflected in its operating cash flow of INR 12.3 billion and free cash flow of INR 5.38 billion. These figures suggest the company is generating positive cash from operations and has the capacity to fund future growth initiatives. However, the capital expenditure of INR 426.7 million indicates ongoing investment in infrastructure and expansion.

    The company's risk profile includes a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential pressure on liquidity. The dilution risk is low, with no significant dilution potential identified in the basic shares outstanding.

    Recent events and filings indicate that the company is under analyst scrutiny, with a mean price target of INR 541.73 and a median price target of INR 550.00. The mean recommendation of 1.93 suggests a generally positive outlook, with 6 strong-buy ratings and 5 buy ratings from analysts.

    Key takeaways
    • Lenskart maintains a conservative capital structure with a debt-to-equity ratio of 0.42.
    • The company's ROE of 4.88% and ROA of 2.84% indicate modest profitability.
    • The company's liquidity position is medium, with a current ratio of 1.94.
    • Analysts have a generally positive outlook, with a mean price target of INR 541.73.
    • The company's growth is supported by positive operating and free cash flows.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $510,75
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $60.99B
    Net cash
    -$25.42B
    Current ratio
    1.9
    Debt / equity
    0.4
    ROA
    2.8%
    ROE
    4.9%
    Cash conversion
    414.0%
    CapEx / revenue
    -6.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution15 analysts
    Strong buy6
    Buy5
    Hold3
    Sell1
    Strong sell0
    12-month price target$541,73 · Median $550,00
    Low $389,00High $625,00
    Operating income · consensus6,7B INR

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$389,00
    Mean$541,73
    Median$550,00
    High$625,00
    Spot$510,75
    +6.1 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,8 %Below median
    Net Margin4,5 %Above median
    ROE4,9 %Above median
    Capex / Rev-6,4 %Below median
    D/E0,42Below median
    Cash Conv4,14Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Lenskart Solutions Ltd Market data — financials · 2026-05-28
    • Lenskart Solutions Ltd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    7.7Kshares short-58.7% vs prior
    1days to cover
    97.9%short of daily vol
    1.1Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    LENS.NSCanonical
    NSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage